NEW YORK, Jan. 31 /Xinhua-PRNewswire/ -- Max Nutrition Inc. (OTC Bulletin Board: MXNU; the "Company") announced today that the Company has completed the share exchange (the "Closing") pursuant to an Agreement and Plan of Reorganization with American Spring Pharmaceutical, Inc., a Delaware corporation ("ASPI"). Pursuant to the Agreement, ASPI transferred 100% of the issued and outstanding shares of Gansu Biology Science and Technology Stock Co., Ltd ("GDBS") to the Company in exchange for 20,000,000 shares of the Company's common stock.
All of the present officers and directors of the Company resigned and Mr. Qi Jinjun, the Chairman and CEO of GDBS, became the sole officer and director of the Company.
"The completion of the share exchange is a great milestone in the development of GDBS; it symbolizes the first step of GDBS to become a truly global player in the fertilizer additive and livestock feed market," remarked Mr. Qi Jinjun. "In the future, we will continue to work hard and reaffirm our commitment to providing high quality fertilizer additives and animal feed for agricultural use."
ASPI, through its wholly owned operating subsidiary Gansu Dasheng Biology Science and Technology Stock Co., Ltd. (GDBS), a limited liability corporation organized under the laws of the People’s Republic of China ("PRC"), engages in the development, production and distribution of additives for fertilizers and animal feed that have been enhanced through the addition of bacteria.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
